Supplementary Results
During the development of the TIPI system we tested different versions of the Ndegron as well as the TEV protease. To illustrate the individual effects of these improvements, we performed a comparative experiment (Supplementary Figure  1A and 1B), where we used strong overexpression of the target fused to different version of the dormant N-degronto show the individual contributions of p14, the point mutant p14* and SF3b155 . Further controls were included to demonstrate N-end rule pathway specificity (ubr1Δ mutant) and the dependency of target protein degradation on TEV expression.
Supplementary Discussion
The Reporter-TDegX constructs can be fused to the N-terminus of any protein of interest. As reporter, we have currently found that different fluorescent proteins and also a Protein A tag can be used (data not shown), however we never tested the functioning of the tag in the complete absence of a reporter. N-terminal gene fusions do not seem to affect the function of most yeast proteins (Kanemaki et al, 2003) , but nevertheless care has to be taken that the generated fusion protein is still functional. Additionally, the N-terminus of the target protein(s) must be accessible to the components of the N-end rule pathway, which is true for soluble cytoplasmic and nuclear proteins in most cases and for many membrane proteins. In yeast, and probably in all other organisms care must be taken that the chosen promoter for the expression of the target is not too strong, but matches the endogenous promoter (e.g. using constructs with the endogenous promoter that can be constructed in different ways) or is even slightly weaker (using commonly used promoters such as the CYC1 or the ADH1 promoter). Functional complementation of the TIPI tagged constructs has to be ensured, but strong overexpression might lead to a situation where levels are not reduced enough by pTEV + expression to cause a phenotype. It has been shown in yeast that the protein levels of many essential genes can be reduced to approx. 10 to 30 % of wild type (using mRNA destabilization (Breslow et al, 2008) ) without evocation of obvious phenotypes. Using the TIPI system we mostly achieved lethal phenotypes when tested with essential genes, which we expressed from weak (CYC1 promoter) to medium strong promoters (ADH1 promoter). These promoters were sufficient to enable complementation, but weak enough to allow depletion of the protein by the TIPI system below a critical level.
Supplementary Figures and Legends
Supplementary Figure 1 : Selective target binding enhances the proteolytic processivity of the TEV protease. (a) Comparision of the processivity of p14*-TEV, p14-TEV and TEV proteases. Activity of the TEV, p14*-TEV, and p14-TEV proteases was assayed using GFP-TEVrec-D-Don1p and GFP-SF3b155 381-424 -TEVrec-D-Don1p as substrates. The TEV constructs were expressed from the inducible GAL1 promoter, GFP-TEVrec-D-Don1p was under control of the strong GDP promoter. The TEV protease constructs were expressed from low copy plasmids. Wild type and ubr1Δ cells were used. TEVrec-D denotes a TEV recognition site with D at position 7 (ENLYFQ-D). p14*-TEV protease exhibits the highest activity because it generates higher levels of D-Don1p and GFP-SF3b155 381-424 -TEVrec by cleavage of GFP-SF3b155 381-424 -TEVrec-D-Don1p as compared to TEV or p14-TEV protease. This experiment demonstrates that selective target binding mediated by the binding of p14 to SF3b155 381-424 increases the processivity of the TEV protease. The point mutant p14* further enhances this. Please note that cleavage of the substrate is only partial. This is due to the strong over expression of target constructs (from the GDP promoter) used for this assay, but also caused by frequent loss of plasmids. This leads to a population of cells that express only GFP-TEVrec-D-Don1p but not the protease. (b) Selective target binding of TEV protease, mediated by the p14*-SF3b155 381-424 interaction, increases the activity of TEV protease. The amounts of the cleavage products GFP-SF3b155 381-424 (in wild type and ubr1Δ cells) and D-Don1p (only in ubr1Δ cells) are proportional to the activity of the different TEV protease variants (with and without fused p14*). TEV protease expression was induced by the addition of galactose (2% final concentration) to the culture. Samples were taken four hours after galactose addition and subjected to western blotting. For detection, anti-GFP, anti-Don1p, and anti-Tub1p antibodies were used. Experimental conditions as described in (a). This experiment provides further evidence that selective target binding of the TEV protease to its substrate enhances significantly the processivity of the protease. We observed no difference in processivity of TEV and p14*-TEV protease towards the target, unless the substrate contained also the SF3b155 381-424 domain. Figure 2 : TIPI of several test proteins. (a) GFP-TDegF-tag modified target proteins show cellular localizations as expected from literature (Huh et al, 2003) . GFP was visualized by fluorescence microscopy using an Zeiss Axiovert 200 equipped with a Hamamatsu camera, an EGFP filter set and a 100 times magnification lens. Used yeast strains are listed in Supplementary materials Table III online. The same yeast strains were used for the growth assays shown in Figure 2a . Scale bar: 1 µm. (b) Efficient deprotection of GFP-TDeg-tagged proteins for N-degron mediated degradation. Cells expressing the fusion proteins GFP-TDegF-Cdc48p, GFP-TDegF-Cdc14p, GFP-TDegF-Cdc5p, GFP-TDegF-Sec12p, or GFP-TDegF-Pma1p were analyzed by western blotting before and 4 hours after induction of pTEV expression by addition of galactose (2% final concentration) addition. For detection, anti-GFP, and anti-Tub1p (loading control) antibodies were used. Please note that the fusion proteins have different molecular weights, but for reasons of simplicity, the bands are placed in the figure next to each other. In addition, different SDS-PAGE gels were used for separation of the crude extracts, either 10% gels (tubulin appears as single band) or 7.5 % gels (two bands). The anti-Tub1p antibody used for detection recognizes α-and β-tubulin, which gives rise to a doublet if the resolution of the gel is high enough.
Supplementary
Supplementary Figure 3 : The pTEV protease cleaves GFP-TDegF near the plasma membrane. Expression of pTEV in GFP-TDegF-Ady2p cells was induced by the addition of galactose at time point 0 minutes. The cells are shown before (-5 minutes) and at several time points after addition (time as indicated in minutes). The GFP moiety of the TDeg-tag was visualized by fluorescence microscopy using a DeltaVision spectris microscope equipped with an EGFP filter set, a 100 times magnification lens, and a Hamamatsu CCD camera set to 2x2 binning. The scale bar represents 2 µm. Figure 4 : Amino acid sequences of the GFP-TDegF-tag and the p14*-TEV protease. (a) Sequence of the GFP-TDegF-tag. The tag consists of the reporter protein yeast enhanced GFP (black) -spacer sequence (orange) -TEV protease recognition site (green) -N-degron (red) -spacer sequence (orange) -SF3B155 381-424 (blue) -spacer sequence (orange) -Methionine (black, start of the protein of interest). The N-terminal amino acid of the N-degron is underlined; it is also part of the TEV protease recognition site. For simplicity, the sequence of yeGFP (Cormack et al, 1997) is not shown completely. (b) Sequence of the fusion protein p14*-TEV protease. The fusion protein consists of p14* (blue) with the D122Y mutation (shown in bold and underscored), a short spacer sequence (orange) and the TEV protease (green). Table I: (Sikorski & Hieter, 1989) pRS414 TRP1 ARS/CEN (Sikorski & Hieter, 1989) pYM-N7 natNT2::P ADH1 (Janke et al, 2004) pYM-N11 natNT2::P CYC1 (Janke et al, 2004) pYM-N15 natNT2::P GPD (Janke et al, 2004) pCT174 natNT2::P GPD -yeGFP-TEVrec-D in pYM-N15 this study pCT187 P GAL1 -TEV in pRS416 this study pCT190-6 P GAL1 -p14*-TEV in pRS416 this study pCT190-11 P GAL1 -p14-TEV in pRS416 this study 
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